Cite
HARVARD Citation
Hung, I. et al. (n.d.). Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial. Lancet infectious diseases. 16 (2), pp. 209-218. [Online].